Stay updated on Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study documents revision history was updated from v3.6.4 to v3.6.5.
    Difference
    0.0%
    Check dated 2026-08-08T18:44:33.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page displays a new revision tag, updating from v3.6.3 to v3.6.4, indicating a small site update.
    Difference
    0.0%
    Check dated 2026-07-25T11:45:36.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing Revision: v3.6.2, indicating an update to the page's underlying version.
    Difference
    0.0%
    Check dated 2026-07-03T23:44:08.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.0 to v3.6.2, signaling a minor platform/software update.
    Difference
    0.0%
    Check dated 2026-06-27T00:20:24.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now includes a 'No longer looking for participants' note indicating that enrollment has ended. Additionally, new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the revision stamp was updated to v3.6.0 while the previous v3.5.5 reference was removed; the Intervention/Treatment heading formatting was adjusted.
    Difference
    0.4%
    Check dated 2026-06-12T14:45:46.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.4 to v3.5.5, signaling a minor update to the page. The study details and eligibility information remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-05T11:31:33.000Z thumbnail image

Stay in the know with updates to Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Brentuximab Vedotin in Older Hodgkin Lymphoma Clinical Trial page.